Back to Search
Start Over
ICN, unit battle over buyback; new CEO suffers reversal in plan to be 'a lot less controversial.'(ICN Pharmaceuticals Inc. in fight with Ribapharm Inc.)
- Source :
- The Wall Street Journal Western Edition. Jan 22, 2003, B5
- Publication Year :
- 2003
- Subjects :
- Valeant Pharmaceuticals International -- Management
Valeant Pharmaceuticals International -- Finance
Valeant Pharmaceuticals International -- Securities
Ribapharm Inc. -- Investor relations
Ribapharm Inc. -- Securities
Pharmaceutical industry -- Securities
Pharmaceutical industry -- Finance
Pharmaceutical industry -- Management
Company business management
Company financing
Company securities
Business
Business, general
Subjects
Details
- ISSN :
- 01932241
- Database :
- Gale General OneFile
- Journal :
- The Wall Street Journal Western Edition
- Publication Type :
- News
- Accession number :
- edsgcl.96726360